Effect of hydroxyselenomethionine on lactation performance, blood profiles, and transfer efficiency in early-lactating dairy cows.

The current study investigated the effects of hydroxyselenomethionine (HMBSe), a novel organic selenium (Se) additive, on lactation performance, blood profiles, antioxidative status, and transfer efficiency of Se in early-lactation dairy cows. Sixty multiparous early-lactating dairy cows with similar days in milk (57 d; standard deviation = 9.9) and milk yield (36.5 kg/d; standard deviation = 1.42) were fed a basal diet containing 0.04 mg of Se/kg (dry matter basis). These cows were assigned to 1 of 4 groups following a randomized complete block design as follows: control (basal diet) or HMBSe addition (0.1, 0.3, or 0.5 mg of Se/kg of dry matter). The experiment lasted for 13 wk, with the first week as adaptation. The results showed that milk yields (raw, protein, and lactose) and feed efficiency were improved in a quadratic manner following increased dietary HMBSe addition, whereas energy-corrected milk, 4% fat-corrected milk, and total solid yields tended to be enhanced quadratically. In terms of whole-blood variables, red blood cell and white blood cell levels were increased quadratically, whereas hemoglobin concentration increased linearly with increased HMBSe addition. Plasma nonesterified fatty acid concentrations tended to increase linearly along with HMBSe addition. Plasma superoxide dismutase activity increased quadratically with increased HMBSe addition. The total antioxidant capacity in plasma tended to improve quadratically when cows were fed more HMBSe. Moreover, plasma malondialdehyde concentrations of dairy cows tended to decrease in a quadratic manner when dietary HMBSe increased. The Se concentrations in milk, plasma, and milk/plasma ratio increased linearly following increased HMBSe addition. In conclusion, HMBSe improved lactation performance, health status, and milk Se concentrations in early-lactating dairy cows.

Effects of dietary adsorbent on milk aflatoxin M1 content and the health of lactating dairy cows exposed to long-term aflatoxin B1 challenge.

The objective of this study was to evaluate the effects of Solis Mos (Novus International Inc., St. Charles, MO) on milk aflatoxin M1 (AFM1) content, lactation performance, plasma biochemical parameters, and ruminal fermentation in dairy cows exposed to long-term aflatoxin B1 (AFB1) challenge. Forty dairy cows were grouped according to days in milk (33 ± 7 d; mean ± SD) and milk production (33.9 ± 3.1 kg) and randomly assigned to 1 of 4 treatments: control (no additive), 20 µg of AFB1/kg of diet dry matter (AF), addition of Solis Mos at 0.25% of diet dry matter (SM), and MIX (AF + SM). The experiment lasted 9 wk, including an adaptation period during the first week. Dry matter intake, milk yield, and milk composition were measured on d 6 and 7 of each week. Milk AFM1, plasma biochemical parameters, and ruminal fermentation variables were analyzed on the last days of wk 1 and 9. No differences were observed in dry matter intake, milk yield, percentages of milk protein, milk fat, and lactose, and somatic cell counts across the treatments. Addition of adsorbent in the AFB1-contaminated diet significantly reduced the milk AFM1 concentrations (0.19 vs. 0.13 µg/kg) and transfer rates (1.38 vs. 0.89%). Dairy cows fed an AFB1-contaminated diet had lower superoxide dismutase activity, total antioxidant capacity, glutathione peroxidase, and levels of IgG and IgA, and higher levels of malondialdehyde in the plasma. Inclusion of Solis Mos in the diet increased the plasma superoxide dismutase activity, total antioxidant capacity, and IgG levels, and decreased the malondialdehyde level. Neither AFB1 nor Solis Mos affected the plasma levels of glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, alkaline phosphatase, or IgM. Long-term inclusion of adsorbent Solis Mos in the diet did not affect lactation performance or liver function, but it reduced milk AFM1 concentrations and oxidative stress and improved the immunological condition and ruminal fermentation in lactating dairy cows exposed to long-term AFB1 challenge.

Transfer of dietary aflatoxin B1 to milk aflatoxin M1 and effect of inclusion of adsorbent in the diet of dairy cows.

The objectives of this study were to investigate the transfer of aflatoxin from feed to milk and to evaluate the effects of Solis Mos (SM; Novus International Inc., St. Charles, MO) on milk aflatoxin M1, plasma biochemical parameters, and ruminal fermentation of dairy cows fed varying doses of aflatoxin B1 (AFB1). Three groups of 8 multiparous Holstein cows in late lactation (days in milk = 271 ± 29; milk yield = 21.6 ± 3.1 kg/d) were assigned to 1 of 3 experiments in a crossover design. Cows in experiment 1 received no aflatoxin, cows in experiment 2 received 20 µg of AFB1/kg of dry matter, and cows in experiment 3 received 40 µg of AFB1/kg of dry matter. Cows in each experiment were assigned to 1 of 2 treatments: control or 0.25% SM. Each experiment consisted of 2 consecutive periods with the first 4 d (d 1 to 4) as adaptation, followed by AFB1 challenge for 7 d (d 5 to 11), and finally clearance for 5 d (d 12 to 16) in each period. Samples of total mixed ration and milk were collected on d 1, 2, and 10 to 14 of each period. Blood samples were collected from the coccygeal vein on d 1, 11, and 14 of each period. Rumen fluid was collected by oral stomach tube 2 h after the morning feeding on d 1 and 11 of each period. Adding SM to basal or AFB1-contaminated diets at 0.25% had no effect on lactation performance, liver function, or immune response. However, addition of SM improved antioxidative status, as indicated by increased plasma concentrations of superoxide dismutase and reduced malondialdehyde regardless of dietary AFB1 level. Addition of SM to the AFB1-free diet eliminated the background AFM1 in milk and increased total ruminal volatile fatty acid (99.6 vs. 94.2 mM) concentrations. Adding SM to the AFB1-contaminated diet in experiment 2 decreased the AFM1 concentration (88.4 vs. 105.3 ng/L) and the transfer of aflatoxin to milk (0.46 vs. 0.56%), and increased total volatile fatty acid concentration (99.8 vs. 93.4 mM). Adding SM to diets with 40 µg/kg of AFB1 did not elicit changes in rumen parameters or AFM1 output. These results indicated that adding SM to diets containing 0 or 20 µg of AFB1/kg decreased milk AFM1 concentration, improved antioxidative status, and altered rumen fermentation, whereas adding SM to a diet containing 40 µg of AFB1/kg did not reduce AFB1 transfer but did increase the antioxidant status of the liver.

p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.

We have recently shown that the adaptor protein p140Cap regulates tumor properties in terms of cell motility and growth. Here, by using the highly metastatic rat adenocarcinoma cell line MTLn3-epidermal growth factor receptor (EGFR), we assess the role of p140Cap in metastasis formation. Orthotopic transplantation of MTLn3-EGFR cells over-expressing p140Cap in Rag2(-/-)γ(c)(-/-) mice resulted in normal primary tumor growth compared with the controls. Strikingly, p140Cap over-expression causes an 80% inhibition in the number of lung metastases. p140Cap over-expressing cells display a 50% reduction in directional cell migration, an increased number and size of focal adhesions, and a strong impairment in the ability to invade in a 3D matrix. p140Cap over-expression affects EGFR signaling and tyrosine phosphorylation of cortactin in response to EGF stimulation. Intriguingly, p140Cap associates with cortactin via interaction with its second proline-rich domain to the cortactin SH3 domain. The phosphomimetic cortactin tyrosine 421 mutant rescues migration and invasive properties in p140Cap over-expressing cells. Taken together, these data demonstrate that p140Cap suppresses the invasive properties of highly metastatic breast carcinoma cells by inhibiting cortactin-dependent cell motility.